Brief: Catalyst Pharmaceuticals Announces Settlement Of Firdapse® (Amifampridine) Patent Litigation With Lupin Pharmaceuticals
25/08/2025 13:16
Aug 25 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O: CATALYST PHARMACEUTICALS ANNOUNCES SETTLEMENT OF FIRDAPSE® (AMIFAMPRIDINE) PATENT LITIGATION WITH LUPIN PHARMACEUTICALS CATALYST PHARMACEUTICALS INC - LUPIN TO DELAY GENERIC FIRDAPSE LAUNCH UNTIL 2035 CATALYST : PENDING FIRDAPSE PATENT LITIGATION AGAINST REMAINING DEFENDANT, HETERO, REGARDING FIRDAPSE'S ORANGE BOOK-LISTED PATENTS IS ONGOING Source text: ID:nGNX7N4cB5 Further company coverage: CPRX.O ((Reuters.Briefs@thomsonreuters.com;))